Cervical Cancer
Capital Medical University, Cancer Institute Describes Research in Cervical Cancer
Published in Women's Health Weekly, February 10th, 2011
2011 FEB 10 -- New investigation results, 'Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173,' are detailed in a study published in Molecular and Cellular Biochemistry. According to recent research published in the journal Molecular and Cellular Biochemistry, "Tyrosine (Y) kinases inhibitors have been approved for targeted treatment of cancer. However, their clinical use is limited to some cancers and the mechanism of their action remains unclear."
"Previous study has indicated that PP2, a selective inhibitor of the Src family of non-receptor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Anti-estrogen medication reduces risk of dying from lung cancer - Avon Products, Inc.
Avon Launches Year-long 125th Anniversary Celebration - Breast Cancer
Data from Lund University, Department of Oncology Advance Knowledge in Breast Cancer - Breast Cancer
Data from Technical University Provide New Insights into Breast Cancer - Breast Cancer
Data on Breast Cancer Described by Researchers at Mayo Clinic College of Medicine, Division of Medical Oncology - Breast Cancer
Data on Breast Cancer Discussed by K.P.M. Suijkerbuijk and Colleagues - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
